ARTICLE | Company News
MediGene gains further Etomoxir rights
February 15, 2001 8:00 AM UTC
MediGene (NMarkt:MDG) gained additional rights from Wolf Research Pharmaceutical (Allensbach, Germany) to its cardiovascular compound, Etomoxir, for use in other indications. MDG, which had rights for...